ClinicalTrials.gg
CompletedNCT04990700Updated Aug 4, 2021

Effect of Partial Rib Resection On the Control of Post-thoracotomy Pain

An interventional study of Partial rib resection in Pain, Postoperative, Iatrogenic Injury and Post-thoracotomy Pain Syndrome, sponsored by Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-04.

Sponsored by Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled May 2019, registered Jul 2021).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,107 studies in Pain, Postoperative with a site in Turkey — 266 open to participants now, 300 under way, none of them phase 3. Pain, Postoperative · Turkey.

Enrollment
851st of 892
35 · median 70
Started
2019
with 53 others
No phase
823 of 1,107
220 open now
Registered
226th of 1,107
by date

Among the 1,107 studies in Pain, Postoperative with a site in Turkey, this one is the 851st largest by enrollment of the 892 interventional ones that give a count, is one of 54 that started in 2019, is one of 823 with no phase, and was the 226th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

266 of the 1,107 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:

261 more — sign in →

All 266 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,107 studies in Pain, Postoperative with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effect of partial rib resection in reducing acute post-thoracotomy pain

Read the detailed description

It is known that severe post thoracotomy pain can be reduced by half with some strategies to prevent pain development. It was thought that partial rib resection would reduce intercostal tension and prevent an uncontrolled fracture. Thus, it is argued that post thoracotomy pain can be reduced. Partial rib resection is applied in clinical practice in selected patient groups. However, we could not find a clinical study on this subject in the English literature. The aim of this study is to determine whether partial rib resection has an effect on the control of thoracotomy pain.

Before the thoracotomy incision, simple randomization will be performed by flipping a coin.

Routine thoracotomy incision will be performed in the control group. In the intervention group, approximately 1 cm segment of the 6th rib will be excised with a rib scissors before the thorax retractor was placed.

Pericostal suture technique will be used in both groups at thoracotomy closure. Demographic information of the cases, preoperative respiratory function parameters, body mass index, Visual Analogue Scale scores, complications and analgesic doses will be recorded in the Case Report Form regularly.

03

Conditions studied

  • Pain, Postoperative
  • Iatrogenic Injury
  • Post-thoracotomy Pain Syndrome

Browse trials for

Keywords

  • Post thoracotomy pain
  • Iatrogenic rib fracture
  • Thoracotomy
  • Partial rib resection
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants who underwent thoracotomy in our clinic in 2019-2020
  • Participants signing an form

Exclusion criteria

Exclusion Criteria:

  • Thoracic wall tumor
  • Invasion of the thoracic wall by extrathoracic
  • Pleural pathology
  • History of previous rib fracture
  • History of previous thoracotomy
  • History of thoracic radiotherapy
  • Emergency surgery
  • Simultaneous incisions other than thoracotomy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
35 participants (actual)

Study arms

  • No intervention
    Control Group

    Includes patients undergoing routine thoracotomy

  • Experimental
    Intervention Group

    The group that will undergo 1 cm partial rib resection during thoracotomy.

    Procedure: Partial rib resection

Interventions

  • ProcedurePartial rib resection

    1 cm partial rib resection during thoracotomy opening

06

What researchers measure

Primary outcomes

  1. Postoperative visual analog scale scores

    Min:1, Max:10 points, Higher scores mean worse outcome

    Time frame: 7 days

Secondary outcomes

  1. Iatrogenic rib fractures

    Yes or no

    Time frame: During operation

  2. Administered analgesic doses

    Milligram

    Time frame: Up to 4 weeks

  3. Duration of drainage

    Days

    Time frame: Up to 4 weeks

  4. Length of hospital stay

    Days

    Time frame: Up to 4 weeks

  5. Number of participants with postoperative bronchopulmonary complications

    Yes or no

    Time frame: Up to 4 weeks

07

Study locations

1 site
  • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
    Istanbul, 34668, Turkey
08

References and documents

Publications

  • Gerner P. Postthoracotomy pain management problems. Anesthesiol Clin. 2008 Jun;26(2):355-67, vii. doi: 10.1016/j.anclin.2008.01.007. PubMed 18456219 ↗
  • Meyers JR, Lembeck L, O'Kane H, Baue AE. Changes in functional residual capacity of the lung after operation. Arch Surg. 1975 May;110(5):576-83. doi: 10.1001/archsurg.1975.01360110122020. PubMed 1093513 ↗
  • Katz J, Jackson M, Kavanagh BP, Sandler AN. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain. 1996 Mar;12(1):50-5. doi: 10.1097/00002508-199603000-00009. PubMed 8722735 ↗
  • Soto RG, Fu ES. Acute pain management for patients undergoing thoracotomy. Ann Thorac Surg. 2003 Apr;75(4):1349-57. doi: 10.1016/s0003-4975(02)04647-7. PubMed 12683601 ↗
  • Wu N, Yan S, Wang X, Lv C, Wang J, Zheng Q, Feng Y, Yang Y. A prospective, single-blind randomised study on the effect of intercostal nerve protection on early post-thoracotomy pain relief. Eur J Cardiothorac Surg. 2010 Apr;37(4):840-5. doi: 10.1016/j.ejcts.2009.11.004. Epub 2009 Dec 1. PubMed 19954996 ↗
  • El-Hag-Aly MA, Hagag MG, Allam HK. If post-thoracotomy pain is the target, Integrated Thoracotomy is the choice. Gen Thorac Cardiovasc Surg. 2019 Nov;67(11):955-961. doi: 10.1007/s11748-019-01126-2. Epub 2019 Apr 16. PubMed 30993532 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2019 to primary completion in Oct 2020, 17 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 17 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2021
First posted
Aug 4, 2021
StartActual
May 9, 2019
Primary completionActual
Oct 27, 2020
CompletionActual
Nov 27, 2020
Last update
Aug 4, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 4, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04990700
Lead sponsor
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Responsible party
İsmail Dal (Principal Investigator, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital) — Principal investigator
First posted
Aug 4, 2021
Start date
May 9, 2019
Primary completion
Oct 27, 2020
Completion
Nov 27, 2020
Last update
Aug 4, 2021

Study contacts

İsmail Dal, PhD
principal investigator · Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion